Search Results - "Burke BP"

Quantitative whole-body dynamic planar scintigraphy in mice with ^99mTc and ¹⁶¹Tb.

Authors: Wright, John D. Renard, Isaline Middleton, Isis A. et al.

Source: EJNMMI Physics. 7/1/2025, Vol. 12 Issue 1, p1-15. 15p.

Structural Characterization of Microcapsules from Common Bee Pollen for the Development of Delivery Systems.

Authors: Ertosun, Seymanur Aylanc, Volkan Peixoto, Andreia F. et al.

Source: Journal of Polymers & the Environment. Feb2025, Vol. 33 Issue 2, p1171-1184. 14p.

Asymmetric rotaxanes as dual-modality supramolecular imaging agents for targeting cancer biomarkers.

Authors: d'Orchymont, Faustine Holland, Jason P.

Source: Communications Chemistry. 6/1/2023, Vol. 6 Issue 1, p1-10. 10p.

Molecular targets and the emerging role of copper radionuclides in prostate cancer theranostics.

Authors: Rodrigues, Diana Fonseca, Alexandra I. Moreira, João N. et al.

Source: EJNMMI Research. 11/18/2025, Vol. 15 Issue 1, p1-33. 33p.

Radiosynthesis and preclinical evaluation of a ⁶⁸Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma.

Authors: Suwattananuruk, Piyapan Yaset, Sukanya Chotipanich, Chanisa et al.

Source: EJNMMI Radiopharmacy & Chemistry. 8/20/2024, Vol. 9 Issue 1, p1-19. 19p.

Perrhenate anion encapsulation in a uranyl ion–zwitterionic dicarboxylate coordination polymer.

Authors: Kusumoto, Sotaro Atoini, Youssef Koide, Yoshihiro et al.

Source: Journal of Inclusion Phenomena & Macrocyclic Chemistry. Jun2024, Vol. 104 Issue 5/6, p209-217. 9p.

CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1.

Authors: Khamaikawin, Wannisa Saisawang, Chonticha Tassaneetrithep, Boonrat et al.

Source: Scientific Reports. 5/13/2024, Vol. 14 Issue 1, p1-13. 13p.

Energy Efficient Location Error Resilient Connectivity in Wireless Sensor Networks.

Authors: Katti, Anvesha Lobiyal, D. K.

Source: Wireless Personal Communications; 2021, Vol. 116 Issue 1, p723-737, 15p

In situ radiochemical doping of functionalized inorganic nanoplatforms for theranostic applications: a paradigm shift in nanooncology.

Authors: Ghosh, Sanchita Liang, Yutong Cai, Weibo et al.

Source: Journal of Nanobiotechnology. 6/2/2025, Vol. 23 Issue 1, p1-36. 36p.

In vivo validation of ⁶⁸Ga-labeled AMD3100 conjugates for PET imaging of CXCR4.

Authors: Renard I Domarkas J Poty S et al.

Source: Nuclear medicine and biology [Nucl Med Biol] 2023 May-Jun; Vol. 120-121, pp. 108335. Date of Electronic Publication: 2023 Apr 05.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9614 (Electronic) Linking ISSN: 09698051 NLM ISO Abbreviation: Nucl Med Biol Subsets: MEDLINE

Biomaterial-based strategies for bone cement: modulating the bone microenvironment and promoting regeneration.

Authors: Jiang, Jiawei Wang, Juan Fan, Pan et al.

Source: Journal of Nanobiotechnology. 5/13/2025, Vol. 23 Issue 1, p1-46. 46p.

Current Trends and Advances in Nanoplatforms-Based Imaging for Cancer Diagnosis.

Authors: Umadevi, Kovuri Sundeep, Dola Vighnesh, Alluru Raghavendra et al.

Source: Indian Journal of Microbiology. Mar2025, Vol. 65 Issue 1, p137-176. 40p.

Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells.

Authors: Carlin, Eric Greer, Braxton Lowman, Kelsey et al.

Source: PLoS Pathogens. 1/19/2021, Vol. 17 Issue 1, p1-31. 31p.

Metal nanoparticles and sensitivity/resistance to therapy in cancer: two sides of the coin?

Authors: Abed, Atena Mirzaei, Seyed Abbas Hosseini, Sayedeh Azimeh et al.

Source: Journal of Nanoparticle Research. Feb2025, Vol. 27 Issue 2, p1-53. 53p.

Sexual and gender minority identity in undergraduate medical education: Impact on experience and career trajectory.

Authors: Madrigal, Josef Rudasill, Sarah Tran, Zachary et al.

Source: PLoS ONE. 11/19/2021, Vol. 16 Issue 11, p1-14. 14p.

Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma.

Authors: Waked, Anthony Crabbé, Melissa Neirinckx, Virginie et al.

Source: EJNMMI Radiopharmacy & Chemistry. 7/15/2024, Vol. 9 Issue 1, p1-23. 23p.

Preparation and preclinical study of [⁶⁸Ga]Ga-(Pip)-Nle-CycMSHhex: Optimized production with an in-house ⁶⁸Ge/⁶⁸Ga generator.

Authors: Shafiei, Sepideh Akbari, Leyla Karimian, Arezoo et al.

Source: Iranian Journal of Nuclear Medicine. Jul2024, Vol. 32 Issue 2, p157-164. 8p.

Safety and efficacy of stereotactic body radiation therapy (SBRT) for the treatment of canine thyroid carcinoma.

Authors: Lee, Ber‐In LaRue, Susan M. Seguin, Bernard et al.

Source: Veterinary & Comparative Oncology. Dec2020, Vol. 18 Issue 4, p843-853. 11p.

Toceranib phosphate in the treatment of canine thyroid carcinoma: 42 cases (2009‐2018).

Authors: Sheppard‐Olivares, Sabina Bello, Nora M. Wood, Elizabeth et al.

Source: Veterinary & Comparative Oncology. Dec2020, Vol. 18 Issue 4, p519-527. 9p.

Gene therapy to cure HIV infection.

Authors: Goguen, Ryan P. Chen, Michelle J. Dunkley, Owen R.S. et al.

Source: Virologie. sep/oct2023, Vol. 27 Issue 5, p63-84. 22p.